Clinical Trials Logo

Clinical Trial Summary

Anemia of Prematurity (AOP) is very common in extremely preterm infants and often leads to blood transfusions. Folic acid, essential for growth and DNA synthesis, is deficient in premature infants. Despite the adoption of folic acid supplementation, evidence supporting its effectiveness in preventing AOP remains scarce. Recommendations for folic acid intake exceed what's naturally found in breast milk, particularly for extremely low birthweight infants. Practices regarding folic acid supplementation vary widely, prompting the need for research. The FACINATE trial aims to determine if additional folic acid supplementation improves hemoglobin levels and reduces late blood transfusions in extremely preterm infants, a question not addressed in current literature.


Clinical Trial Description

Anemia of prematurity (AOP) affects nearly all extremely preterm or extremely low birthweight (ELBW; birthweight <1000 g) infants. AOP's development involves various factors such as exacerbation of newborn physiological anemia, reduced response to erythropoietin after birth, frequent blood sampling, short lifespan of red blood cells, and rapid blood volume increase during growth. To manage this anemia, most infants receive packed red blood cell transfusions, often based on specific hemoglobin thresholds. Despite efforts to minimize transfusion needs in ELBW infants, over 80% still require transfusions during their initial hospital stay. However, these transfusions come with potential adverse effects like infections, immune imbalances, lung and gut injuries, bronchopulmonary dysplasia, and retinopathy of prematurity. Folic acid is crucial for fetal and postnatal development, playing a central role in DNA synthesis and supporting cell division. Its deficiency can hinder DNA synthesis, cause erythroblast apoptosis, and lead to anemia due to ineffective erythropoiesis. Preterm infants often lack sufficient folic acid, even more so in unfortified breast milk, which contains lower levels than recommended for adequate intake. Supplementing folic acid for preterm infants began in the early 1990s based on limited studies on low-birth-weight (LBW) infants, primarily formula-fed and weighing >1000 grams. Despite its widespread use, there's insufficient robust evidence specifying the ideal dosage or confirming its effectiveness in preventing AOP or improving hemoglobin levels. Unfortified breast milk's folic acid content falls short of recommended levels, especially for ELBW infants due to limited hepatic stores and rapid growth. Fortified breast milk or preterm formulas provide varying amounts of folic acid but might still be insufficient, especially for infants on restricted fluid intake due to lung injury. The FACINATE trial aims to investigate whether additional supplementation of 50 mcg/day of folic acid improves hemoglobin levels and reduces late (>14 days of age) blood transfusions in extremely preterm infants, a specific question not yet explored in existing literature. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06220461
Study type Interventional
Source University of Calgary
Contact Belal Alshaikh, MD, MSc
Phone (403) 956 1588
Email belal.alshaikh@ahs.ca
Status Not yet recruiting
Phase N/A
Start date June 1, 2024
Completion date July 31, 2028

See also
  Status Clinical Trial Phase
Recruiting NCT05134116 - SafeBoosC III Two-year Follow-up
Active, not recruiting NCT03714633 - Stockholm Preterm Interaction-Based Intervention N/A
Not yet recruiting NCT05490173 - The Pilot Experimental Study of the Neuroprotective Effects of Exosomes in Extremely Low Birth Weight Infants N/A
Active, not recruiting NCT04459117 - Prophylactic Treatment of the Ductus Arteriosus in Preterm Infants by Acetaminophen Phase 2/Phase 3
Completed NCT03649282 - HFNC and NCPAP in Extremely Preterm Infants N/A
Completed NCT01773902 - Protein for Premies N/A
Completed NCT04121897 - Therapist Education and Massage for Parent Infant-Outcomes N/A
Recruiting NCT04413097 - Delayed Cord Clamping With Oxygen In Extremely Low Gestation Infants N/A
Recruiting NCT05265195 - PeriviAble DeLiveries: ALIgning PArental aNd PhysiCian PrioritiEs (ALLIANCE)
Completed NCT05686252 - RCT: The Effect of Held Position During Kangaroo Care on Physiological Parameters of Premature Infants N/A
Recruiting NCT06027645 - Early Intervention Based on Neonatal Crawling in Very Premature Infants at Risk For Neurodevelopmental Disorder N/A
Completed NCT04074525 - Evaluating Decisional Regret Among Mothers
Completed NCT05152875 - Relationship Between Fungal Colonization and Severe Bronchopulmonary Dysplasia
Completed NCT02782637 - Prenatal Counseling in Extreme Prematurity: Parents' View N/A
Recruiting NCT04715373 - LISA in the Delivery Room for Extremely Preterm Infants N/A
Not yet recruiting NCT05334550 - Effectiveness of Home Based Early Intervention of Extremely Premature Infant by Parent N/A
Recruiting NCT05248477 - Improve the Survival Without Morbidity of Extremely Preterm Infants (PREMEX) N/A
Completed NCT04652063 - Osteopathic Manipulative Medicine to Reduce Developmental Delays N/A
Completed NCT04256889 - Use Of Nfant(R) Technology Feeding System For Infants Less Than 30 Weeks GA N/A
Not yet recruiting NCT03786497 - Protecting Brains and Saving Futures - the PBSF Protocol